{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T18:46:20Z","timestamp":1648925180867},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.antiviral.2013.07.002","type":"journal-article","created":{"date-parts":[[2013,7,13]],"date-time":"2013-07-13T13:46:20Z","timestamp":1373723180000},"page":"14-19","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye model"],"prefix":"10.1016","volume":"100","author":[{"given":"James M.","family":"Hill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan M.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Partha S.","family":"Bhattacharjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Malamud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Clement","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter J.","family":"Lukiw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto C.","family":"Ochoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy P.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cruz","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Harris E.","family":"McFerrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.07.002_b0005","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1167\/iovs.08-2077","article-title":"Effective treatment of ocular HSK with a human apolipoprotein E mimetic peptide in a mouse eye model","volume":"49","author":"Bhattacharjee","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.antiviral.2013.07.002_b0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/02713680802647662","article-title":"A human apolipoprotein E mimetic peptide effectively inhibits HSV-1 TK-positive and TK-negative acute epithelial keratitis in rabbits","volume":"34","author":"Bhattacharjee","year":"2009","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.antiviral.2013.07.002_b0015","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1167\/iovs.07-0302","article-title":"Evaluation of a theta-defensin in a Murine model of herpes simplex virus type 1 keratitis","volume":"48","author":"Brandt","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.antiviral.2013.07.002_b0020","series-title":"Nonparametric Analysis of Longitudinal Data in Factorial Experiments","author":"Brunner","year":"2001"},{"key":"10.1016\/j.antiviral.2013.07.002_b0025","doi-asserted-by":"crossref","first-page":"36018","DOI":"10.1074\/jbc.M204849200","article-title":"Peptides containing membrane-transiting motifs inhibit virus entry","volume":"277","author":"Bultmann","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.07.002_b0030","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/AOG.0b013e3181fc3b1a","article-title":"Contraceptive efficacy, acceptability, and safety of C31G and nonoxynol-9 spermicidal gels: a randomized controlled trial","volume":"116","author":"Burke","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.antiviral.2013.07.002_b0035","first-page":"335","article-title":"A non-antibiotic antimicrobial mixture (C31G): evaluation of the antimicrobial efficiency of C31G on vaginal cultures","volume":"131","author":"Calis","year":"1992","journal-title":"Boll. Chim. Farm."},{"key":"10.1016\/j.antiviral.2013.07.002_b0040","series-title":"Fields Virology","first-page":"448","article-title":"Antiviral agents","author":"Coen","year":"2007"},{"key":"10.1016\/j.antiviral.2013.07.002_b0045","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1128\/AAC.32.3.350","article-title":"C31G, a new agent for oral use with potent antimicrobial and antiadherence properties","volume":"32","author":"Corner","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.07.002_b0050","unstructured":"Dmitrienko A., Chuang-Stein, C., D\u2019Agostino, R., 2007. Pharmaceutical Statistics Using SAS: A Practical Guide, Cary."},{"key":"10.1016\/j.antiviral.2013.07.002_b0055","series-title":"Herpes Simplex Virus Protocols","first-page":"291","article-title":"Pathogenesis and molecular biology of ocular HSV in the rabbit","author":"Hill","year":"1998"},{"key":"10.1016\/j.antiviral.2013.07.002_b0060","series-title":"Color Atlas of Ophthalmology","first-page":"405","article-title":"Ocular pharmacology","author":"Hill","year":"2009"},{"key":"10.1016\/j.antiviral.2013.07.002_b0065","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.antiviral.2011.11.015","article-title":"Efficacy of ASP2151, a helicase-primase inhibitor, against thymidine kinase-deficient herpes simplex virus type 2 infection in vitro and in vivo","volume":"93","author":"Himaki","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.07.002_b0070","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/AAC.43.2.314","article-title":"A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses","volume":"43","author":"Howett","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.07.002_b0075","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1167\/iovs.12-10250","article-title":"A cationic peptide, TAT-Cd0, inhibits Herpes Simplex Virus Type 1 Ocular infection in vivo","volume":"54","author":"Jose","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.antiviral.2013.07.002_b0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.virol.2012.09.023","article-title":"Snapshots: chromatin control of viral infection","volume":"435","author":"Knipe","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.07.002_b0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0166-3542(99)00044-3","article-title":"Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate","volume":"43","author":"Krebs","year":"1999","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.07.002_b0090","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1586\/eri.12.143","article-title":"The rise of epigenetic targets for the development of novel antivirals","volume":"10","author":"Kristie","year":"2012","journal-title":"Expert. Rev. Anti. Infect. Ther."},{"key":"10.1016\/j.antiviral.2013.07.002_b0095","first-page":"984","article-title":"Effect of iontophoretic and topical application of antiviral agents in treatment of experimental HSV-1 keratitis in rabbits","volume":"18","author":"Kwon","year":"1979","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.antiviral.2013.07.002_b0100","first-page":"1","article-title":"A novel selective LSD1\/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency","volume":"4","author":"Liang","year":"2013","journal-title":"Mol. Biol."},{"key":"10.1016\/j.antiviral.2013.07.002_b0105","doi-asserted-by":"crossref","first-page":"167ra5","DOI":"10.1126\/scitranslmed.3005145","article-title":"Targeting the JMJD2 histone demethylases to epigenetically control herpesvirus infection and reactivation from latency","volume":"5","author":"Liang","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2013.07.002_b0110","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/jop.2005.21.463","article-title":"Dipeptide monoester ganciclovir prodrugs for treating HSV-1-induced corneal epithelial and stromal keratitis: in vitro and in vivo evaluations","volume":"21","author":"Majumdar","year":"2005","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2013.07.002_b0115","first-page":"621","article-title":"Anti-viral activity of microbicides in model systems","volume":"12","author":"Malamud","year":"1998","journal-title":"Int. Conf. AIDS"},{"key":"10.1016\/j.antiviral.2013.07.002_b0120","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ajpath.2012.04.014","article-title":"Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus","volume":"181","author":"Mulik","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.antiviral.2013.07.002_b0125","doi-asserted-by":"crossref","first-page":"413453","DOI":"10.1155\/2012\/413453","article-title":"Efficacy of bidens pilosa extract against herpes simplex virus infection in vitro and in vivo","volume":"2012","author":"Nakama","year":"2012","journal-title":"Evid. Based. Complement. Alternat. Med."},{"key":"10.1016\/j.antiviral.2013.07.002_b0130","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/01.olq.0000216022.18321.d3","article-title":"Vaginal and rectal topical microbicide development: safety and efficacy of 1.0% Savvy (C31G) in the pigtailed macaque","volume":"33","author":"Patton","year":"2006","journal-title":"Sex Transm. Dis."},{"key":"10.1016\/j.antiviral.2013.07.002_b0135","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0010-7824(96)00066-2","article-title":"Assessment of the anti-microbial agent C31G as a spermicide: comparison with nonoxynol-9","volume":"53","author":"Thompson","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.antiviral.2013.07.002_b0140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/08820530802111085","article-title":"Ocular HSV-1 latency, reactivation, and recurrent disease","volume":"23","author":"Toma","year":"2008","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.antiviral.2013.07.002_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/612316","article-title":"Rabbit and mouse models of HSV-1 latency, reactivation, and recurrent eye disease","volume":"2012","author":"Webre","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.antiviral.2013.07.002_b0150","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/0002-9394(72)90463-1","article-title":"Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers","volume":"73","author":"Wellings","year":"1972","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.antiviral.2013.07.002_b0155","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1128\/AAC.41.6.1335","article-title":"The microbicidal agent C31G inhibits Chlamydia trachomatis infectivity in vitro","volume":"41","author":"Wyrick","year":"1997","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213001897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213001897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T04:19:57Z","timestamp":1563423597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213001897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0166354213001897"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.07.002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye model","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}